Adaptive Biotechnologies Corp (ADPT)
Healthcare
Diagnostics & Research
22.60 $
-6.7%
vs. previous close
Closing price · As of: 31. Jul 2026
Adaptive Biotechnologies Corp (ADPT) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 72 million $. Tick rows to compare them in a chart.
| Tick rows to compare them in a chart (up to 4) | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 38 | 46 | 42 | 43 | 46 | 47 | 52 | 59 | 94 | 72 | 71 | 72 | 308 | |
| 19 | 20 | 18 | 19 | 17 | 18 | 17 | 18 | 18 | 18 | 19 | 20 | 75 | |
| 19 | 26 | 24 | 24 | 30 | 29 | 35 | 41 | 76 | 53 | 52 | 51 | 233 | |
| 29 | 29 | 30 | 25 | 24 | 23 | 24 | 24 | 24 | 22 | 24 | 19 | 88 | |
| 20 | 21 | 20 | 18 | 17 | 18 | 17 | 18 | 18 | 20 | 21 | 21 | 80 | |
| 70 | 97 | 73 | 71 | 62 | 63 | 65 | 66 | 66 | 66 | 71 | 77 | 280 | |
| -51 | -71 | -49 | -47 | -33 | -34 | -30 | -25 | 10 | -13 | -19 | -26 | -47 | |
| 3.7 | 3.0 | 3.0 | 2.7 | 2.9 | 3.0 | 2.9 | 2.9 | 3.0 | 3.0 | 2.9 | 2.7 | 12 | |
| -50 | -69 | -48 | -46 | -32 | -34 | -30 | -26 | 9.5 | -14 | -20 | -40 | -64 | |
| -5.8 | 0.0 | 4.2 | 0.0 | – | – | – | – | – | – | – | – | – | |
| -50 | -69 | -48 | -46 | -32 | -34 | -30 | -26 | 9.5 | -14 | -20 | -40 | -64 | |
| -41 | -61 | -39 | -39 | -25 | -26 | -30 | -18 | 17 | -6.4 | -14 | -34 | -37 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.